HomeCDTX • NASDAQ
add
Cidara Therapeutics Inc
Previous close
$113.05
Day range
$109.36 - $116.62
Year range
$10.14 - $121.21
Market cap
2.95B USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.50M | 37.00% |
Net income | -25.72M | 71.80% |
Net profit margin | — | — |
Earnings per share | -1.65 | 92.01% |
EBITDA | -31.29M | -182.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 510.58M | 210.63% |
Total assets | 534.33M | 208.22% |
Total liabilities | 33.15M | -21.85% |
Total equity | 501.17M | — |
Shares outstanding | 25.36M | — |
Price to book | 5.24 | — |
Return on assets | -21.57% | — |
Return on capital | -24.17% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.72M | 71.80% |
Cash from operations | -40.96M | — |
Cash from investing | 0.00 | — |
Cash from financing | 383.38M | — |
Net change in cash | 342.42M | — |
Free cash flow | -33.66M | — |
About
Founded
2012
Headquarters
Website
Employees
38
